DT DTILPrecision BioSciences, Inc. - Common Stock | NASDAQ | US$ 6,61 | US$ 84,78 mi | — | 0,92x | -49,57% | — | Preço 15/09/2026
SEC 31/12/2025 |
LI LIMNLiminatus Pharma, Inc. - Class A Common Stock | NASDAQ | US$ 3,47 | US$ 82,42 mi | — | -8,40x | 103,99% | — | Preço 11/09/2026
SEC 31/12/2025 |
CG CGTXCognition Therapeutics, Inc. - Common Stock | NASDAQ | US$ 1,04 | US$ 75,68 mi | — | 2,21x | -68,53% | — | Preço 18/09/2026
SEC 31/12/2025 |
CS CSBRChampions Oncology, Inc. - Common Stock | NASDAQ | US$ 4,77 | US$ 65,98 mi | — | 16,22x | -28,88% | — | Preço 15/09/2026
SEC 30/04/2026 |
IN INMBINmune Bio Inc. - Common stock | NASDAQ | US$ 2,22 | US$ 54,96 mi | — | 2,34x | -195,26% | — | Preço 11/09/2026
SEC 31/12/2025 |
EX EXOZeXoZymes Inc. - Common Stock | NASDAQ | US$ 6,30 | US$ 52,82 mi | — | 15,55x | -269,59% | — | Preço 11/09/2026
SEC 31/12/2025 |
AL ALGSAligos Therapeutics, Inc. - Common stock | NASDAQ | US$ 5,24 | US$ 51,80 mi | — | 0,97x | -45,18% | — | Preço 18/09/2026
SEC 31/12/2025 |
KL KLRSKalaris Therapeutics, Inc. - Common Stock | NASDAQ | US$ 3,38 | US$ 51,61 mi | — | 0,65x | -55,11% | — | Preço 11/09/2026
SEC 31/12/2025 |
IN INKTMiNK Therapeutics, Inc. - Common Stock | NASDAQ | US$ 12,00 | US$ 51,25 mi | — | -3,60x | 87,82% | — | Preço 11/09/2026
SEC 31/12/2025 |
TI TILInstil Bio, Inc. - Common Stock | NASDAQ | US$ 7,45 | US$ 49,68 mi | — | 0,44x | -62,68% | — | Preço 14/09/2026
SEC 31/12/2025 |
MG MGXMetagenomi Therapeutics, Inc. - Common Stock | NASDAQ | US$ 1,16 | US$ 43,21 mi | — | 0,27x | -55,40% | — | Preço 11/09/2026
SEC 31/12/2025 |
PT PTHSPelthos Therapeutics Inc. Common Stock | NYSE American | US$ 21,90 | US$ 41,18 mi | — | 1,06x | -111,41% | — | Preço 11/09/2026
SEC 31/12/2025 |
TC TCRXTScan Therapeutics, Inc. - Common Stock | NASDAQ | US$ 0,31 | US$ 39,75 mi | — | 0,32x | -105,40% | — | Preço 14/09/2026
SEC 31/12/2025 |
EL ELUTElutia, Inc. - Class A Common Stock | NASDAQ | US$ 0,81 | US$ 37,21 mi | 0,93x | 1,34x | 192,90% | — | Preço 11/09/2026
SEC 31/12/2025 |
AT ATYRaTyr Pharma, Inc. - Common Stock | NASDAQ | US$ 0,36 | US$ 33,75 mi | — | 0,50x | -110,15% | — | Preço 18/09/2026
SEC 31/12/2025 |
LO LONALeonaBio, Inc. - Common Stock | NASDAQ | US$ 7,16 | US$ 30,61 mi | — | 1,10x | -380,03% | — | Preço 14/09/2026
SEC 31/12/2025 |
TV TVGNTevogen Inc. - Common Stock | NASDAQ | US$ 7,36 | US$ 24,43 mi | — | -2,97x | 319,08% | — | Preço 11/09/2026
SEC 31/12/2025 |
ES ESLAEstrella Immunopharma, Inc. - Common Stock | NASDAQ | US$ 0,66 | US$ 24,29 mi | — | -2,34x | 126,02% | — | Preço 11/09/2026
SEC 31/12/2025 |
OT OTLKOutlook Therapeutics, Inc. - Common Stock | NASDAQ | US$ 0,66 | US$ 22,97 mi | — | -0,71x | 193,94% | — | Preço 11/09/2026
SEC 30/09/2025 |
GN GNTAGenenta Science S.p.A. - American Depositary Shares | NASDAQ | US$ 0,84 | US$ 19,70 mi | — | 0,90x | -29,90% | — | Preço 11/09/2026
SEC 31/12/2025 |
PA PASGPassage Bio, Inc. - Common Stock | NASDAQ | US$ 5,00 | US$ 15,86 mi | — | 0,85x | -242,72% | — | Preço 11/09/2026
SEC 31/12/2025 |
DY DYAIDyadic International, Inc. - Common Stock | NASDAQ | US$ 0,48 | US$ 15,79 mi | — | 12,81x | -597,58% | — | Preço 11/09/2026
SEC 31/12/2025 |
CR CRISCuris, Inc. - Common Stock | NASDAQ | US$ 1,13 | US$ 14,88 mi | — | 2,72x | -138,81% | — | Preço 15/09/2026
SEC 31/12/2025 |
JS JSPRJasper Therapeutics, Inc. - Class A Common Stock | NASDAQ | US$ 0,66 | US$ 12,66 mi | — | 3,05x | -1.826,09% | — | Preço 11/09/2026
SEC 31/12/2025 |
PL PLURPluri Inc. - Common Stock | NASDAQ | US$ 1,18 | US$ 11,50 mi | — | -0,66x | 136,64% | — | Preço 11/09/2026
SEC 30/06/2026 |
RG RGENRepligen Corporation - Common Stock | NASDAQ | US$ 166,28 | US$ 9,40 mi | 193,35x | 0,00x | 2,32% | — | Preço 14/09/2026
SEC 31/12/2025 |
SN SNTISenti Biosciences Holdings, Inc. - Common Stock | NASDAQ | US$ 0,31 | US$ 6,88 mi | — | 1,23x | -1.099,27% | — | Preço 11/09/2026
SEC 31/12/2025 |
CV CVMCel-Sci Corporation Common Stock | NYSE American | US$ 1,48 | US$ 6,00 mi | — | 0,38x | -159,25% | — | Preço 15/09/2026
SEC 30/09/2025 |
IN INTSIntensity Therapeutics, Inc. - Common Stock | NASDAQ | US$ 4,02 | US$ 5,45 mi | — | 0,46x | -97,73% | — | Preço 11/09/2026
SEC 31/12/2025 |
IN INABIN8bio, Inc. - Common Stock | NASDAQ | US$ 1,07 | US$ 4,68 mi | — | 0,17x | -70,54% | — | Preço 11/09/2026
SEC 31/12/2025 |
PM PMCBPharmaCyte Biotech, Inc. - Common Stock | NASDAQ | US$ 0,45 | US$ 3,77 mi | — | 0,11x | -58,34% | — | Preço 11/09/2026
SEC 30/04/2026 |
IO IOVAIovance Biotherapeutics, Inc. - Common Stock | NASDAQ | US$ 8,60 | US$ 3,07 mi | — | 0,00x | -55,97% | — | Preço 11/09/2026
SEC 31/12/2025 |
CE CELZCreative Medical Technology Holdings, Inc. - Common Stock | NASDAQ | US$ 0,97 | US$ 2,30 mi | — | 0,31x | -79,67% | — | Preço 18/09/2026
SEC 31/12/2025 |
VI VIVSVivoSim Labs, Inc. - Common Stock | NASDAQ | US$ 0,28 | US$ 732,76 mil | — | -0,67x | 1.259,60% | — | Preço 11/09/2026
SEC 31/03/2026 |
SL SLXNSilexion Therapeutics Corp - Ordinary Shares | NASDAQ | US$ 0,36 | US$ 475,04 mil | 0,04x | 0,18x | -457,63% | — | Preço 11/09/2026
SEC 31/12/2025 |
AI AIMAIM ImmunoTech Inc. Common Stock | NYSE American | US$ 0,21 | US$ 335,86 mil | — | -0,03x | 142,68% | — | Preço 18/09/2026
SEC 31/12/2025 |
SR SRZNSurrozen, Inc. - Common Stock | NASDAQ | US$ 19,00 | US$ 142,08 mil | — | -0,00x | 128,90% | — | Preço 11/09/2026
SEC 31/12/2025 |
SC SCLXScilex Holding Company - Common Stock | NASDAQ | US$ 5,01 | US$ 55,28 mil | — | -0,00x | 176,65% | — | Preço 11/09/2026
SEC 31/12/2025 |
CL CLDICalidi Biotherapeutics, Inc. Common Stock | NYSE American | US$ 1,10 | US$ 4,73 mil | — | 0,00x | -529,56% | — | Preço 18/09/2026
SEC 31/12/2025 |
AG AGMBAgomAb Therapeutics NV - ADRs representing one common share. | NASDAQ | US$ 12,17 | — | — | — | — | — | Preço 18/09/2026
SEC — |
AT ATTOAttovia Therapeutics, Inc. - Common Stock | NASDAQ | US$ 22,14 | — | — | — | — | — | Preço 18/09/2026
SEC — |
BC BCDABioCardia, Inc. - Common Stock | NASDAQ | US$ 1,17 | — | — | — | -919,33% | — | Preço 18/09/2026
SEC 31/12/2025 |
BK BKHABlack Hawk Acquisition Corporation - Class A Ordinary Shares | NASDAQ | US$ 11,99 | — | — | — | -34,57% | — | Preço 18/09/2026
SEC 30/11/2025 |
BN BNTXBioNTech SE - American Depositary Shares | NASDAQ | US$ 96,06 | — | — | — | -5,91% | — | Preço 18/09/2026
SEC 31/12/2025 |
| BSBSEMBioStem Technologies, Inc. - Common Stock | NASDAQ | US$ 4,74 | — | — | — | — | — | Preço 18/09/2026
SEC — |
CA CABACabaletta Bio, Inc. - Common Stock | NASDAQ | US$ 2,55 | — | — | — | -149,80% | — | Preço 18/09/2026
SEC 31/12/2025 |
CG CGEMCullinan Therapeutics, Inc. - Common Stock | NASDAQ | US$ 21,08 | — | — | — | -53,80% | — | Preço 18/09/2026
SEC 31/12/2025 |
CL CLLSCellectis S.A. - American Depositary Shares | NASDAQ | US$ 1,53 | — | — | — | -89,05% | — | Preço 18/09/2026
SEC 31/12/2025 |
CM CMPXCompass Therapeutics, Inc. - Common Stock | NASDAQ | US$ 1,90 | — | — | — | -33,79% | — | Preço 18/09/2026
SEC 31/12/2025 |
CO COAGHemab Therapeutics Holdings, Inc. - Common Stock | NASDAQ | US$ 41,19 | — | — | — | — | — | Preço 18/09/2026
SEC — |
EI EIKNEikon Therapeutics, Inc. - Common Stock | NASDAQ | US$ 8,94 | — | — | — | — | — | Preço 11/09/2026
SEC — |
IM IMAImageneBio, Inc. - Common Stock | NASDAQ | US$ 5,08 | — | — | — | -34,06% | — | Preço 11/09/2026
SEC 31/12/2025 |
OC OCGNOcugen, Inc. - Common Stock | NASDAQ | US$ 1,06 | — | — | — | 557,67% | — | Preço 14/09/2026
SEC 31/12/2025 |
OD ODTXOdyssey Therapeutics, Inc. - Common Stock | NASDAQ | US$ 24,67 | — | — | — | — | — | Preço 14/09/2026
SEC — |
OK OKYOOKYO Pharma Limited - Ordinary Shares | NASDAQ | US$ 1,40 | — | — | — | 84,80% | — | Preço 11/09/2026
SEC 31/03/2025 |
PR PROKProKidney Corp. - Class A Ordinary Shares | NASDAQ | US$ 1,80 | — | — | — | 6,82% | — | Preço 11/09/2026
SEC 31/12/2025 |
RL RLAYRelay Therapeutics, Inc. - Common Stock | NASDAQ | US$ 19,15 | — | — | — | -48,76% | — | Preço 14/09/2026
SEC 31/12/2025 |
SC SCTXScribe Therapeutics Inc. - Common Stock | NASDAQ | US$ 29,74 | — | — | — | — | — | Preço 11/09/2026
SEC — |
SL SLBTSL Science Holding Limited - Ordinary Shares | NASDAQ | US$ 2,06 | — | — | — | — | — | Preço 11/09/2026
SEC — |
